Top News

Apr 17, 2015
Pharmaceutical Technology
WHO says that results from clinical trials should be reported within 12 months of completion of the study
Apr 15, 2015
Pharmaceutical Technology
This is the first time a single strategy document for both EMA and HMA is presented, reflecting the need for a coordinated approach to address the challenges and opportunities facing the European regulatory system network.
Apr 15, 2015
By Pharmaceutical Technology Editors
Pfizer announces that its Phase III trial for Ibrance met its primary endpoint and was ended early due to efficacy based on an assessment by an independent Data Monitoring Committee.
Apr 14, 2015
Spending on prescription medications reached $373.9 billion in 2014, representing the largest increase in 13 years.
Apr 10, 2015
The grants will be offered to investigators conducting research in the field of PCSK9 biology.
Apr 08, 2015
By Pharmaceutical Technology Editors
Mylan announces that it would offer Perrigo $29 billion in cash and stock to buy the Irish company.
Apr 07, 2015
Novartis will make payments to Juno to settle a patent dispute covering chimeric antigen receptor T-cell (CAR-T) therapies.
Apr 02, 2015
By Pharmaceutical Technology Editors
NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.
Apr 01, 2015
By Pharmaceutical Technology Editors
USP announces an implementation date of Jan. 1, 2018 for General Chapters <232> Elemental Impurities—Limits and <2232> Elemental Contaminants in Dietary Supplements.
Mar 26, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The WHO report outlines possible policies that may help governments reduce the high prices of new medicines.
native1_300x100
lorem ipsum